PharmaRoth Labs, Inc. (ROTH)

[sweetlou]

An interesting find... This company is testing metformin delivered in the gut in a delayed fashion where it decreases systemic effects but still stimulates release of GLP-1 and related effects to lower blood sugar in type 2 diabetes. Interestingly, they presented some phase 2b study findings at the same 2013 annual meeting of European Association for Study of Diabetes (EASD) where Dr. Rojas presented the Sucanon study in Latino prediabetics. The link below outlines some further progress in phase 2b just announced in November 2016. They are a private company but have millions upon millions in venture capital signed on. Just some food for thought as we await the Sucanon trial results vs metformin, the most widely prescribed oral medication worldwide, and gold standard first line treatment per ADA.

http://elcelyx.com/wp-content/uploads/2015/06/EASD-Curtain-Raiser-FINAL.pdf

By the way, their product is most assuredly not a fraud either, and I see more than a few similarities in terms of timing and scientific potential